Lee YS - Search Results

1

The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis.

Chang Y, Jeong SW, Jang JY, Eun H, Lee YS, Song DS, Yu SJ, Lee SH, Kim W, Lee HW, Kim SG, Ryu S, Park S. Chang Y, et al. Among authors: lee sh, lee ys, lee hw. J Liver Cancer. 2022 Sep;22(2):167-177. doi: 10.17998/jlc.2022.09.19. Epub 2022 Sep 29. J Liver Cancer. 2022. PMID: 37383408 Free PMC article.

2

Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms.

Lee YS, Seo YS, Kim JH, Lee J, Kim HR, Yoo YJ, Kim TS, Kang SH, Suh SJ, Joo MK, Jung YK, Lee BJ, Yim HJ, Yeon JE, Kim JS, Park JJ, Um SH, Bak YT, Byun KS. Lee YS, et al. Among authors: lee bj, lee j. Gut Liver. 2018 Jan 15;12(1):94-101. doi: 10.5009/gnl17040. Gut Liver. 2018. PMID: 28873509 Free PMC article.

3

Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.

Lee HA, Kim SU, Seo YS, Lee YS, Kang SH, Jung YK, Kim MY, Kim JH, Kim SG, Suk KT, Jung SW, Jang JY, An H, Yim HJ, Um SH. Lee HA, et al. Among authors: lee ys. Liver Int. 2019 Jun;39(6):1071-1079. doi: 10.1111/liv.14036. Epub 2019 Feb 6. Liver Int. 2019. PMID: 30589490

4

Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study.

Kim MA, Kim SU, Sinn DH, Jang JW, Lim YS, Ahn SH, Shim JJ, Seo YS, Baek YH, Kim SG, Kim YS, Kim JH, Choe WH, Yim HJ, Lee HW, Kwon JH, Lee SW, Jang JY, Kim HY, Park Y, Kim GA, Yang H, Lee HA, Koh M, Lee YS, Kim M, Chang Y, Kim YJ, Yoon JH, Zoulim F, Lee JH. Kim MA, et al. Among authors: lee sw, lee ha, lee ys, lee hw, lee jh. Gut. 2020 Dec;69(12):2214-2222. doi: 10.1136/gutjnl-2019-320015. Epub 2020 Mar 24. Gut. 2020. PMID: 32209606

5

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.

Ahn YE, Suh SJ, Yim HJ, Seo YS, Yoon EL, Kim TH, Lee YS, Yim SY, Kim HR, Kang SH, Jung YK, Kim JH, Yeon JE, Um SH, Byun KS. Ahn YE, et al. Among authors: lee ys. Gut Liver. 2021 Mar 15;15(2):284-294. doi: 10.5009/gnl19367. Gut Liver. 2021. PMID: 32307975 Free PMC article.

6

Management of liver diseases during the pandemic of coronavirus disease-19.

Cho JY, Kim SS, Lee YS, Song DS, Lee JH, Kim JH. Cho JY, et al. Among authors: lee ys, lee jh. Clin Mol Hepatol. 2020 Jul;26(3):243-250. doi: 10.3350/cmh.2020.0111. Epub 2020 Jun 23. Clin Mol Hepatol. 2020. PMID: 32570302 Free PMC article. No abstract available.

7

Tenofovir-based combination therapy or monotherapy for multidrug-resistant chronic hepatitis B: Long-term data from a multicenter cohort study.

Yim HJ, Suh SJ, Jung YK, Hwang SG, Seo YS, Um SH, Lee SH, Kim YS, Jang JY, Kim IH, Kim HS, Kim JH, Lee YS, Yoon EL, Song MJ, Park JY. Yim HJ, et al. Among authors: lee sh, lee ys. J Viral Hepat. 2020 Dec;27(12):1306-1318. doi: 10.1111/jvh.13363. Epub 2020 Aug 20. J Viral Hepat. 2020. PMID: 32706461

8

Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea.

Lee MJ, Chang SW, Kim JH, Lee YS, Cho SB, Seo YS, Yim HJ, Hwang SY, Lee HW, Chang Y, Jang JY. Lee MJ, et al. Among authors: lee ys, lee hw. Invest New Drugs. 2021 Feb;39(1):260-268. doi: 10.1007/s10637-020-00977-4. Epub 2020 Aug 4. Invest New Drugs. 2021. PMID: 32749658

9

Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study.

Kim TH, Seo YS, Kang SH, Kim MY, Kim SG, Lee HY, Lee JH, Lee YS, Kim JH, Jeong SW, Jang JY, Suk KT, Jung YK, An H, Yim HJ, Kim YS, Um SH; Korean Study Group of Portal Hypertension. Kim TH, et al. Among authors: lee ys, lee jh, lee hy. Liver Int. 2020 Dec;40(12):3083-3092. doi: 10.1111/liv.14631. Liver Int. 2020. PMID: 32750739

10

Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma.

Lee HA, Lee YS, Kim BK, Jung YK, Kim SU, Park JY, Kim JH, An H, Kim DY, Yim HJ, Ahn SH, Yeon JE, Byun KS, Han KH, Um SH, Seo YS. Lee HA, et al. Among authors: lee ys. Gut Liver. 2021 May 15;15(3):420-429. doi: 10.5009/gnl20101. Gut Liver. 2021. PMID: 32839362 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,244 results

Search Page